pubmed-article:20236364 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20236364 | lifeskim:mentions | umls-concept:C0337810 | lld:lifeskim |
pubmed-article:20236364 | lifeskim:mentions | umls-concept:C0026882 | lld:lifeskim |
pubmed-article:20236364 | lifeskim:mentions | umls-concept:C0017431 | lld:lifeskim |
pubmed-article:20236364 | lifeskim:mentions | umls-concept:C1456409 | lld:lifeskim |
pubmed-article:20236364 | lifeskim:mentions | umls-concept:C0033105 | lld:lifeskim |
pubmed-article:20236364 | lifeskim:mentions | umls-concept:C1521761 | lld:lifeskim |
pubmed-article:20236364 | lifeskim:mentions | umls-concept:C0683598 | lld:lifeskim |
pubmed-article:20236364 | lifeskim:mentions | umls-concept:C0242356 | lld:lifeskim |
pubmed-article:20236364 | lifeskim:mentions | umls-concept:C1011526 | lld:lifeskim |
pubmed-article:20236364 | pubmed:issue | 8 | lld:pubmed |
pubmed-article:20236364 | pubmed:dateCreated | 2010-8-10 | lld:pubmed |
pubmed-article:20236364 | pubmed:abstractText | To evaluate whether etravirine (TMC125) might be effective in patients failing therapy with current nonnucleoside reverse transcriptase inhibitors (NNRTIs), we analysed the prevalence of TMC125 mutations and the possible determinants of genotypic resistance to this drug among sequences reported to a large database in Italy [Antiretroviral Resistance Cohort Analysis (ARCA)]. | lld:pubmed |
pubmed-article:20236364 | pubmed:language | eng | lld:pubmed |
pubmed-article:20236364 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20236364 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20236364 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20236364 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20236364 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20236364 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20236364 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20236364 | pubmed:month | Sep | lld:pubmed |
pubmed-article:20236364 | pubmed:issn | 1468-1293 | lld:pubmed |
pubmed-article:20236364 | pubmed:author | pubmed-author:VitielloPP | lld:pubmed |
pubmed-article:20236364 | pubmed:author | pubmed-author:ZazziMM | lld:pubmed |
pubmed-article:20236364 | pubmed:author | pubmed-author:AntinoriAA | lld:pubmed |
pubmed-article:20236364 | pubmed:author | pubmed-author:FrancisciDD | lld:pubmed |
pubmed-article:20236364 | pubmed:author | pubmed-author:MonnoLL | lld:pubmed |
pubmed-article:20236364 | pubmed:author | pubmed-author:MaggioloFF | lld:pubmed |
pubmed-article:20236364 | pubmed:author | pubmed-author:BoeriEE | lld:pubmed |
pubmed-article:20236364 | pubmed:author | pubmed-author:PunzoAA | lld:pubmed |
pubmed-article:20236364 | pubmed:author | pubmed-author:RusconiSS | lld:pubmed |
pubmed-article:20236364 | pubmed:author | pubmed-author:Di BiagioAA | lld:pubmed |
pubmed-article:20236364 | pubmed:author | pubmed-author:CallegariGG | lld:pubmed |
pubmed-article:20236364 | pubmed:author | pubmed-author:PetitA GAG | lld:pubmed |
pubmed-article:20236364 | pubmed:author | pubmed-author:BruzzoneBB | lld:pubmed |
pubmed-article:20236364 | pubmed:author | pubmed-author:AdorniFF | lld:pubmed |
pubmed-article:20236364 | pubmed:author | pubmed-author:Di VincenzoPP | lld:pubmed |
pubmed-article:20236364 | pubmed:author | pubmed-author:Antiretrovira... | lld:pubmed |
pubmed-article:20236364 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20236364 | pubmed:volume | 11 | lld:pubmed |
pubmed-article:20236364 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20236364 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20236364 | pubmed:pagination | 530-4 | lld:pubmed |
pubmed-article:20236364 | pubmed:meshHeading | pubmed-meshheading:20236364... | lld:pubmed |
pubmed-article:20236364 | pubmed:meshHeading | pubmed-meshheading:20236364... | lld:pubmed |
pubmed-article:20236364 | pubmed:meshHeading | pubmed-meshheading:20236364... | lld:pubmed |
pubmed-article:20236364 | pubmed:meshHeading | pubmed-meshheading:20236364... | lld:pubmed |
pubmed-article:20236364 | pubmed:meshHeading | pubmed-meshheading:20236364... | lld:pubmed |
pubmed-article:20236364 | pubmed:meshHeading | pubmed-meshheading:20236364... | lld:pubmed |
pubmed-article:20236364 | pubmed:meshHeading | pubmed-meshheading:20236364... | lld:pubmed |
pubmed-article:20236364 | pubmed:meshHeading | pubmed-meshheading:20236364... | lld:pubmed |
pubmed-article:20236364 | pubmed:meshHeading | pubmed-meshheading:20236364... | lld:pubmed |
pubmed-article:20236364 | pubmed:meshHeading | pubmed-meshheading:20236364... | lld:pubmed |
pubmed-article:20236364 | pubmed:meshHeading | pubmed-meshheading:20236364... | lld:pubmed |
pubmed-article:20236364 | pubmed:meshHeading | pubmed-meshheading:20236364... | lld:pubmed |
pubmed-article:20236364 | pubmed:meshHeading | pubmed-meshheading:20236364... | lld:pubmed |
pubmed-article:20236364 | pubmed:meshHeading | pubmed-meshheading:20236364... | lld:pubmed |
pubmed-article:20236364 | pubmed:meshHeading | pubmed-meshheading:20236364... | lld:pubmed |
pubmed-article:20236364 | pubmed:meshHeading | pubmed-meshheading:20236364... | lld:pubmed |
pubmed-article:20236364 | pubmed:meshHeading | pubmed-meshheading:20236364... | lld:pubmed |
pubmed-article:20236364 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20236364 | pubmed:articleTitle | Prevalence of mutations and determinants of genotypic resistance to etravirine (TMC125) in a large Italian resistance database (ARCA). | lld:pubmed |
pubmed-article:20236364 | pubmed:affiliation | Sezione Malattie Infettive e Immunopatologia, Dipartimento di Scienze Cliniche 'Luigi Sacco', Universita' degli Studi, Milan, Italy. | lld:pubmed |
pubmed-article:20236364 | pubmed:publicationType | Journal Article | lld:pubmed |